Market research
GHC.F Garofalo Health Care S.p.A
F EUR Healthcare
Latest close
As of 29 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 465M
- P/E ratio
- 25.05
- Analyst target
- Not available
- Dividend yield
- 1.7%
- Beta
- 0.37
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- ISIN
- IT0005345233
- Market cap
- 465M
- P/E ratio
- 25.05
- Analyst target
- Not available
- Dividend yield
- 1.7%
- Beta
- 0.37
About
About Garofalo Health Care S.p.A
Garofalo Health Care S.p.A., together with its subsidiaries, operates healthcare clinics in Italy. It operates through Hospital and Social/Dependency Care segments. The company offers high-complexity surgery, medium- and low-complexity surgery, emergency surgery, medicine, clinical and interventional cardiology, and extended and intensive care units, as well as motor, neurological, cardiac, and nutritional rehabilitation. It also operates centers for patients in coma and persistent vegetative states; and psychiatric and diagnostic centers. The company was founded in 2000 and is based in Rome, Italy. Garofalo Health Care S.p.A. is a subsidiary of Larama 98 S.p.A.
Research context
Garofalo Health Care S.p.A appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Care Facilities
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the GHC.F discussion.
5 years, 7 months ago
Garofalo Health Care S.p.A is currently in a long term uptrend where the price is trading 11.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.2.
Finally, its free cash flow fell by 57.0% to $2M since the same quarter in the previous year.
Based on the above factors, Garofalo Health Care S.p.A gets an overall score of 2/5.